Overview

Zofin to Treat COVID-19 Long Haulers

Status:
Not yet recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and potential efficacy of Zofin administered intravenously in subjects experiencing prolonged symptoms (> 6 weeks and < 12 months) of COVID-19.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Organicell Regenerative Medicine

Collaborator:

Proxima Clinical Research, Inc.